Regenerative Medical Technology Group Inc. (RMTG) stock
RMTGOTCRetail-Retail Stores, NECFiscal year ends December 31
$0.04−0.00 (-5.76%)
Close on Oct 19, 2026Market cap $497.25KP/E –Yield –
Regenerative Medical Technology operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Regenerative Medical Technology's operating cash flow for the twelve months ending Jun 30, 2026 was $268.56K, up 141.2% year over year. For fiscal 2025 it was -$706.52K, down 183.1% from the year before. The highest annual figure on record is $850.70K in fiscal 2024.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$706.52K | -183.1% |
| FY2024 | Dec 31, 2024 | $850.70K | – |
| FY2023 | Dec 31, 2023 | -$419.20K | – |
| FY2022 | Dec 31, 2022 | -$1.11M | – |
| FY2021 | Dec 31, 2021 | -$9.88M | – |
| FY2020 | Dec 31, 2020 | -$322.75K | – |
| FY2019 | Dec 31, 2019 | -$362.33K | – |
| FY2018 | Dec 31, 2018 | -$244.64K | – |
| FY2017 | Dec 31, 2017 | -$6.12K | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $331.97K | – |
| Q1 FY2026 | Mar 31, 2026 | $102.12K | +78.8% |
| Q4 FY2025 | Dec 31, 2025 | $38.20K | -89.9% |
| Q3 FY2025 | Sep 30, 2025 | -$203.73K | -174.6% |
| Q2 FY2025 | Jun 30, 2025 | -$598.09K | -761.6% |
| Q1 FY2025 | Mar 31, 2025 | $57.11K | -47.1% |
| Q4 FY2024 | Dec 31, 2024 | $379.39K | – |
| Q3 FY2024 | Sep 30, 2024 | $272.94K | +2592.3% |
| Q2 FY2024 | Jun 30, 2024 | $90.40K | – |
| Q1 FY2024 | Mar 31, 2024 | $107.97K | +1493.6% |
| Q4 FY2023 | Dec 31, 2023 | -$29.40K | – |
| Q3 FY2023 | Sep 30, 2023 | $10.14K | – |
| Q2 FY2023 | Jun 30, 2023 | -$406.71K | – |
| Q1 FY2023 | Mar 31, 2023 | $6.78K | – |
| Q4 FY2022 | Dec 31, 2022 | -$49.43K | – |
| Q3 FY2022 | Sep 30, 2022 | -$152.18K | – |
| Q2 FY2022 | Jun 30, 2022 | -$396.43K | – |
| Q1 FY2022 | Mar 31, 2022 | -$516.11K | – |
| Q4 FY2021 | Dec 31, 2021 | -$8.75M | – |
| Q3 FY2021 | Sep 30, 2021 | -$430.66K | – |
| Q2 FY2021 | Jun 30, 2021 | -$544.31K | – |
| Q1 FY2021 | Mar 31, 2021 | -$154.86K | – |
| Q4 FY2020 | Dec 31, 2020 | -$96.94K | – |
| Q3 FY2020 | Sep 30, 2020 | -$92.10K | – |
| Q2 FY2020 | Jun 30, 2020 | -$69.03K | – |
| Q1 FY2020 | Mar 31, 2020 | -$64.68K | – |
| Q4 FY2019 | Dec 31, 2019 | -$48.45K | – |
| Q3 FY2019 | Sep 30, 2019 | -$134.68K | – |
| Q2 FY2019 | Jun 30, 2019 | -$86.57K | – |
| Q1 FY2019 | Mar 31, 2019 | -$92.63K | – |
| Q4 FY2018 | Dec 31, 2018 | -$73.87K | – |
| Q3 FY2018 | Sep 30, 2018 | -$68.21K | – |
| Q2 FY2018 | Jun 30, 2018 | -$67.63K | – |
| Q1 FY2018 | Mar 31, 2018 | -$34.94K | – |
See a number that looks wrong?